The effect of Pioglitazone in arteriosclerosis obliterans(ASO) patients with type 2 diabetes mellitus or impaired glucose tolerance
Not Applicable
- Conditions
- Arteriosclerosis obliterans(ASO) patients with type 2 diabetes mellitus or impaired glucose tolerance
- Registration Number
- JPRN-UMIN000005057
- Lead Sponsor
- Sanda City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with cardiac failure at present or in the past Patients with severe renal dysfunction Patients with severe liver dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of Ankle Brachial Pressure Index(ABI), pulse wave velocity(PWV), Acceleration Time, Wave pattern, pulse wave, adiponectin, blood glucose level, lipid metabolism, blood pressure and BMI at 3month after administration of Pioglitazone
- Secondary Outcome Measures
Name Time Method Statistical involvement of primary outcomes